Study reveals novel immune-based biomarker helps detect ovarian cancer years before conventional diagnosis

Graphical abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101612 Researchers at Children’s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The findings were published today in the journal Cell Reports Medicine. High-grade ovarian cancer (HGOC) is the fifth-leading cause of cancer-related death among women. More than 90% of women are diagnosed when the disease has reached advanced stages and has already spread, presenting significant treatment challenges. Ovarian cancer is highly treatable Read More

Related posts:

  1. Research confirms circZFR is a promising biomarker for colorectal cancer diagnosis and prognosis
  2. Reinvigorating exhausted immune cells reveals potential therapy target for cancer
  3. Study suggests AI may soon be able to detect cancer
  4. Circadian rhythm drives the release of important immune cells, study reveals
  5. New study reveals immune protein’s critical role in neuronal function and aging
  6. AI-powered tool helps doctors detect rare diseases
  7. Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker
  8. Team reveals why new tuberculosis vaccine induces a stronger, longer response than the conventional vaccine

Leave a Reply

Your email address will not be published. Required fields are marked *